drugset / Trial / NCT00195845

A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder

NCT00195845

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine if galantamine augmentaion improves cognition in euthymic bipolar patients. In addition, the effect of galantamine on clinical measures of functioning and psychopathology will also be assessed.

Timeline

Start
2003-04
Primary completion
2006-09
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule

Indications